Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

20
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
20
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

18
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
18
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

17
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

16
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
16
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

17
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
17

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 Registry.

Current vascular pharmacology·2026
Same author

"Frailty and cognitive impairment are associated with early adverse clinical events and angiographic differences in older adults with acute coronary syndrome".

European journal of cardiovascular nursing·2026
Same author

Achieving High Smoking Abstinence Rates After Myocardial Infarction: A Cardiology-Led Intervention Within Cardiac Rehabilitation.

European journal of preventive cardiology·2026
Same author

Preterm Birth and Maternal Cardiovascular Risk.

European cardiology·2026
Same author

Early effectiveness of anifrolumab in systemic lupus erythematosus: real-life data a 3 and 6 months from RALESA registry.

Medicina clinica·2026
Same author

Intra-Individual Variability of Lipoprotein(a) After Acute Coronary Syndrome: A Long-Term Cohort Study.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Aug 18, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.6K

Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination.

Ana I Molina-Ramos1,2, Elisabeth Gómez-Moyano3, Jorge Rodríguez-Capitán1,2

  • 1Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.

Journal of Clinical Medicine
|December 11, 2022
PubMed
Summary
This summary is machine-generated.

Myocarditis, a heart condition, can be a consequence of COVID-19 and mRNA vaccines. This review examines its epidemiology and prognosis, balancing risks against vaccination benefits.

Keywords:
COVID-19mRNA vaccinesmyocarditis

More Related Videos

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.0K
Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

2.5K

Related Experiment Videos

Last Updated: Aug 18, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.6K
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.0K
Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

2.5K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Coronavirus disease 2019 (COVID-19) has caused significant global morbidity and mortality.
  • Myocarditis, a heart inflammation, is a notable consequence of COVID-19 with potentially poor prognosis.
  • The epidemiology and specific prognosis of COVID-19-related myocarditis remain largely unknown.

Purpose of the Study:

  • To review the etiopathogenesis, epidemiology, clinical features, diagnosis, prognosis, and treatment of myocarditis associated with SARS-CoV-2 infection.
  • To analyze myocarditis occurring secondary to COVID-19 mRNA vaccination.
  • To contextualize myocarditis risk within the overall public health benefits of COVID-19 vaccination.

Main Methods:

  • This study is a narrative review.
  • Literature search on SARS-CoV-2, COVID-19, myocarditis, and mRNA vaccines.
  • Synthesis of existing data on the topic.

Main Results:

  • Myocarditis is a recognized complication of COVID-19.
  • Myocarditis is also a rare adverse event associated with mRNA COVID-19 vaccines.
  • Data on the specific epidemiology and long-term prognosis of COVID-19-related myocarditis is still emerging.

Conclusions:

  • Myocarditis requires consideration as a potential consequence of both COVID-19 and its vaccination.
  • The benefits of COVID-19 vaccination are substantial and should be weighed against the rare risk of myocarditis.
  • Further research is needed to fully elucidate the epidemiology and prognosis of COVID-19-associated myocarditis.